- Home
- RNAC vs SEG Comparison
RNAC vs SEG Comparison
Compare RNAC & SEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- SEG
- Stock Information
- Founded
- RNAC 2007
- SEG 2024
- Country
- RNAC United States
- SEG United States
- Employees
- RNAC N/A
- SEG N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- SEG
- Sector
- RNAC Health Care
- SEG
- Exchange
- RNAC Nasdaq
- SEG NYSE
- Market Cap
- RNAC 291.7M
- SEG N/A
- IPO Year
- RNAC 2016
- SEG N/A
- Fundamental
- Price
- RNAC $10.42
- SEG $19.79
- Analyst Decision
- RNAC Strong Buy
- SEG
- Analyst Count
- RNAC 7
- SEG 0
- Target Price
- RNAC $41.00
- SEG N/A
- AVG Volume (30 Days)
- RNAC 86.8K
- SEG 69.8K
- Earning Date
- RNAC 05-08-2025
- SEG 05-12-2025
- Dividend Yield
- RNAC N/A
- SEG N/A
- EPS Growth
- RNAC N/A
- SEG N/A
- EPS
- RNAC N/A
- SEG N/A
- Revenue
- RNAC $34,173,000.00
- SEG $78,565,000.00
- Revenue This Year
- RNAC N/A
- SEG N/A
- Revenue Next Year
- RNAC N/A
- SEG N/A
- P/E Ratio
- RNAC N/A
- SEG N/A
- Revenue Growth
- RNAC 31.91
- SEG 9.05
- 52 Week Low
- RNAC $8.85
- SEG $16.52
- 52 Week High
- RNAC $41.87
- SEG $36.50
- Technical
- Relative Strength Index (RSI)
- RNAC 39.42
- SEG N/A
- Support Level
- RNAC $11.18
- SEG N/A
- Resistance Level
- RNAC $13.10
- SEG N/A
- Average True Range (ATR)
- RNAC 0.90
- SEG 0.00
- MACD
- RNAC 0.04
- SEG 0.00
- Stochastic Oscillator
- RNAC 24.61
- SEG 0.00
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.